BPW
PFE icon

BlueDoor Private Wealth’s Pfizer PFE Stock Holding History

BlueDoor Private Wealth’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$310K Sell
12,888
-490
-4% -$12.8K 0.13% 125
2026
Q1 		$376K Hold
13,378
– – 0.17% 111
2025
Q4 		$333K Buy
+13,378
New +$337K 0.15% 118

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BlueDoor Private Wealth's PFE Position: Q2 2026 in Review

BlueDoor Private Wealth reduced its Pfizer (PFE) stake by 3.7% in Q2 2026, selling an estimated $12.8K and leaving 12,888 shares worth $310K. The position accounts for 0.13% of the portfolio, ranked #125.

BlueDoor Private Wealth first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $376K in Q1 2026. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • BlueDoor Private Wealth held 12,888 shares of Pfizer worth $310K as of Q2 2026.
  • BlueDoor Private Wealth sold 490 Pfizer shares in Q2 2026, an estimated $12.8K.
  • Pfizer made up 0.13% of BlueDoor Private Wealth's portfolio in Q2 2026, its #125 holding.
  • BlueDoor Private Wealth first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • BlueDoor Private Wealth's Pfizer position peaked at $376K in Q1 2026.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on BlueDoor Private Wealth's 13F filing for Q2 2026, filed 16 Jul 2026.